Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effect of the women's health initiative on prescription anti-osteoporosis medication utilization.

Farley JF, Blalock SJ, Cline RR.

Osteoporos Int. 2008 Nov;19(11):1603-12. doi: 10.1007/s00198-008-0607-1. Epub 2008 Mar 29.

PMID:
18373048
2.

Osteoporosis management in a Medicaid population after the Women's Health Initiative study.

Lee E, Wutoh AK, Xue Z, Hillman JJ, Zuckerman IH.

J Womens Health (Larchmt). 2006 Mar;15(2):155-61.

PMID:
16536679
3.

Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing.

Lee E, Maneno MK, Wutoh AK, Zuckerman IH.

J Womens Health (Larchmt). 2010 May;19(5):847-54. doi: 10.1089/jwh.2009.1441.

4.

Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.

Rigby AJ, Ma J, Stafford RS.

Menopause. 2007 Sep-Oct;14(5):853-8.

PMID:
17429334
5.
6.

Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.

Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK.

J Bone Miner Res. 2006 May;21(5):765-71.

7.
8.

Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.

Heinemann K, Rübig A, Strothmann A, Nahum GG, Heinemann LA.

J Womens Health (Larchmt). 2008 Sep;17(7):1151-66. doi: 10.1089/jwh.2007.0584.

PMID:
18774896
9.

Patients' and clinicians' attitudes after the Women's Health Initiative study.

Blümel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gómez MS, Sarrá S.

Menopause. 2004 Jan-Feb;11(1):57-61.

PMID:
14716183
10.

Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.

Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD.

Ann Intern Med. 2014 May 6;160(9):594-602. doi: 10.7326/M13-2348.

11.

Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey.

Sawka AM, Huh A, Dolovich L, Papaioannou A, Eva K, Thabane L, Gafni A, Cullimore A, Macdougall M, Steiner M, Adachi JD.

J Obstet Gynaecol Can. 2004 Nov;26(11):967-73.

PMID:
15560859
12.

Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study.

Huot L, Couris CM, Tainturier V, Jaglal S, Colin C, Schott AM.

Osteoporos Int. 2008 Jul;19(7):1047-54. doi: 10.1007/s00198-008-0587-1. Epub 2008 Mar 29.

PMID:
18373055
13.

Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.

Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.

Menopause. 2006 Jan-Feb;13(1):125-9.

PMID:
16607108
14.

Osteoporosis in the Women's Health Initiative: Another Treatment Gap?

Sattari M, Cauley JA, Garvan C, Johnson KC, LaMonte MJ, Li W, Limacher M, Manini T, Sarto GE, Sullivan SD, Wactawski-Wende J, Beyth RJ.

Am J Med. 2017 Aug;130(8):937-948. doi: 10.1016/j.amjmed.2017.02.042. Epub 2017 Mar 31.

PMID:
28366425
15.

Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.

Gerend MA, Aiken LS, Erchull MJ, Lapin A.

Prev Med. 2006 Sep;43(3):158-64. Epub 2006 Jun 5.

PMID:
16750263
17.

Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.

Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S.

Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):17-27.

PMID:
16794994
18.

Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.

Overman RA, Gourlay ML, Deal CL, Farley JF, Brookhart MA, Layton JB.

Osteoporos Int. 2015 May;26(5):1515-24. doi: 10.1007/s00198-014-3022-9. Epub 2015 Jan 20.

19.

Racial variations in antiresorptive medication use: results from the 2000 Medical Expenditure Panel Survey (MEPS).

Farley JF, Cline RR, Gupta K.

Osteoporos Int. 2006;17(3):395-404. Epub 2005 Nov 29.

PMID:
16314982
20.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877

Supplemental Content

Support Center